Effect of Magnesium Sulfate on Eicosanoid Levels in Women with Pregnancy-Induced Hypertension

References

• Horn E. To tilfaelde af eclampsia gravidarum behandlet med sulfas magnesicus injicereti Rygmarvens subarachnoidalrum. Med Rev (Bergen) 1906; 23: 264–72
   Google Scholar
• Lazard E M. A preliminary report on the intravenous use of magnesium sulphate in puerperal eclampsia. Am J Obstet Gynecol 1925; 9: 178–88
   Google Scholar
• Dorsett L. The intramuscular injection of magnesium sulfate for the control of convulsions in eclampsia. Am J Obstet Gynecol 1926; 11: 227–31
   Google Scholar
• McNeile L G. Conservative treatment of late toxemias of pregnancy, with special reference to the intravenous use of magnesium sulphate. JAMA 1934; 103: 548–52
   Google Scholar
• Borges L F, Gucer G. Effect of magnesium sulfate on epileptic foci. Epilepsia 1978; 19: 81–90
   PubMedGoogle Scholar
• Pritchard J A. The use of magnesium sulfate in preeclampsia-eclampsia. J Reprod Med 1978; 23: 107–14
   Google Scholar
• Somjen G, Hilmy M, Stephen C R. Failure to anesthetize human subjects by intravenous administration of magnesium sulfate. J Pharmacol Exp Ther 1966; 154: 652–9
   PubMed Web of Science ®Google Scholar
• Hilmy M I, Somjen G G. Distribution and tissue uptake of magnesium related to its pharmacological effects. Am J Physiol 1968; 214: 406–13
   PubMedGoogle Scholar
• Hibbard B J, Rosen M. The management of severe preeclampsia and eclampsia. Br J Anaesth 1977; 49: 3–9
   PubMed Web of Science ®Google Scholar
• Friedman S A. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol 1988; 71: 122–37
   PubMed Web of Science ®Google Scholar
• Walsh S W. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985; 152: 335–40
   PubMed Web of Science ®Google Scholar
• Spitz B, Magness R R, Cox S M, Brown C EL, Rosenfeld C R, Gant N F. Low-dose aspirin.I. effect on angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II. Am J Obstet Gynecol 1988; 159: 1035–43
   PubMed Web of Science ®Google Scholar
• Brown C EL, Gant N F, Cox K, Spitz B, Rosenfeld C R, Magness R R. Low-dose aspirin. II. relationship of angiotensin II pressor responses, circulating eicosanoids, and pregnancy outcome. Am J Obstet Gynecol 1990; 163: 1853–61
   PubMed Web of Science ®Google Scholar
• Everett R B, Worley R J, MacDonald P C, Gant N F. Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy. J Clin Endocrinol Metab 1978; 46: 1007–10
   PubMed Web of Science ®Google Scholar
• Fitzgerald D J, Entmann S S, Mulloy K, Fitzgerald G A. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987; 75: 956–63
   PubMed Web of Science ®Google Scholar
• Goodman R P, Killam A P, Brash A R, Branch R A. Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension. Am J Obstet Gynecol 1982; 142: 817–22
   PubMed Web of Science ®Google Scholar
• Magness R R. Endothelium-derived vasoactive substances and uterine blood vessels. Semin Perinatol 1991; 15: 68–78
   PubMed Web of Science ®Google Scholar
• Magness R R, Mitchell M D, Rosenfeld C R. Uteroplacental production of eicosanoids in ovine pregnancy. Prostaglandins 1990; 39: 75–88
   PubMedGoogle Scholar
• Magness R R, Osei-Boaten K, Mitchell M D, Rosenfeld C R. In vitro prostacyclin production by ovine uterine and systemic arteries: effects of angiotensin II. J Clin Invest 1985; 76: 2206–12
   PubMed Web of Science ®Google Scholar
• Magness R R, Rosenfeld C R. Calcium modulation of endothelium-derived prostacyclin production in ovine pregnancy. Endocrinology 1993; 132: 2445–52
   PubMed Web of Science ®Google Scholar
• Bussolino F, Benedetto C, Massobariom M, Camussi G. Maternal vascular prostacyclin activity in preeclampsia. Lancet 1980; 2: 702
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Mori N. 6-keto prostaglandin F1α, thromboxane B2, and 13, 14-dihydro-15-keto prostaglandin F concentrations of normotensive and preeclamptic patients during pregnancy, delivery and the postpartum period. Am J Obstet Gynecol 1985; 151: 121–7
   PubMed Web of Science ®Google Scholar
• Beaufils M, Uzan S, Donsimoni R, Colau J C. Prevention of preeclampsia by early antiplatelet therapy. Lancet 1985; 1: 840–42
   PubMed Web of Science ®Google Scholar
• Wallenburg H CS, Dekker G A, Makovitz J W, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 1–3
   PubMed Web of Science ®Google Scholar
• Schiff E, Peleg E, Goldenberg M, Rosenthal T, Ruppin E, Tamarkin M, Barkai G, Ben-Baruch G, Yahal T, Blankstein J, Goldman B, Mashiach S. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989; 321: 351–6
   PubMed Web of Science ®Google Scholar
• Altura D M, Altura B T, Carella A. Magnesium deficiency-induced spasms of umbilical vessels: relation to preeclampsia, hypertension, growth retardation. Science 1983; 221: 376–8
   PubMed Web of Science ®Google Scholar
• Briel R C, Lippert T H. Action of magnesium sulfate on platelet prostacyclin interaction and prostacyclin of blood vessels. Am J Obstet Gynecol 1985; 153: 232
   PubMedGoogle Scholar
• Watson K Y, Moldow C F, Ogburn P L, Jacob H S. Magnesium sulfate: rationale for its use in preeclampsia. Proc Natl Acad Sci USA 1986; 83: 1075–8
   PubMed Web of Science ®Google Scholar
• Branch D W, Dudley D J, LaMarche S, Mitchell M D. Sera from preeclamptic patients contain factor(s) that stimulate prostacyclin production by human endothelial cells. Prostaglandins Leukotrienes Essentials Fatty Acids 1992; 45: 191–5
   PubMed Web of Science ®Google Scholar
• Nadler J, Goodson S, Rude R. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 1987; 9: 379–83
   PubMed Web of Science ®Google Scholar
• Dusting G J, Moncada S, Vane J R. Prostacyclin: its biosynthesis, actions, and clinical potential. Adv Prostaglandin Thromboxane Leukotriene Res 1982; 10: 59–106
   PubMedGoogle Scholar
• Granstrom E, Diczfalusy U, Hamberg M, Hansson G, Malmsten C, Samuelsson B. Thromboxane A2: biosynthesis and effects on platelets. Adv Prostaglandin Thromboxane Leukotriene Res 1982; 10: 15–58
   PubMedGoogle Scholar
• Campbell W B, Ojeda S R. Measurements of prostaglandins by radioimmunoassay. Methods Enzymol 1987; 141: 323–48
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Misiani R, Muratore D, Marchesi D, Livio M, Schieppati A, Mecca G, deGaetano G, Donati M. Prostacyclin and human foetal circulation. Prostaglandins 1979; 18: 341–8
   PubMed Web of Science ®Google Scholar
• Kawano M, Mori N. Prostacyclin producing activity of human umbilical, placental and uterine vessels. Prostaglandins 1983; 26: 645–62
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Rosenfeld C R, Magness R R. Angiotensin II and α-agonist. III. in vitro fetal-maternal placental prostaglandins. Am J Physiol 1991; 260: E8–13
   Google Scholar
• Robinson B F, Collier J G, Karim S MM, Sommers K. Effect of prostaglandins A1, A2, B1, E2 and F2α on forearm arterial bed and superficial hand veins in man. Clin Sci 1973; 44: 367–76
   PubMedGoogle Scholar
• Novy M J, Piasecki G, Jackson B T. Effect of prostaglandins E2 and F2α on umbilical blood flow and fetal hemodynamics. Prostaglandins 1974; 5: 543–55
   PubMedGoogle Scholar
• McLaughlin M K, Brennan S C, Chez R A. Vasoconstrictive effects of prostaglandins in sheep placental circulation. Am J Obstet Gynecol 1978; 130: 408–13
   PubMedGoogle Scholar
• Maigaard S, Forman A, Andersson K-E. Relaxant and contractile effects of some amines and prostanoids in myometrial and vascular smooth muscle within the human uteroplacental unit. Acta Physiol Scand 1986; 128: 33–40
   PubMedGoogle Scholar
• O'Brien W F, Williams M C, Benoit R, Sawai S K, Knuppel R A. The effect of magnesium sulfate infusion on systemic and renal prostacyclin production. Prostaglandins 1990; 40: 529–38
   PubMedGoogle Scholar
• Cotton D B, Gonik B, Dorman K F. Cardiovascular alterations in sever pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate. Am J Obstet Gynecol 1984; 148: 162–5
   PubMed Web of Science ®Google Scholar
• Hensby C N, Jogee M, Myatt L. Comparison of GC-MS and RIA methods for 6-oxo-PGF1α. Prog Lipid Res 1981; 20: 779–82
   PubMedGoogle Scholar